Virtus Biotech ETF BBP

Morningstar Medalist Rating

Morningstar’s Analysis BBP

Will BBP outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Virtus LifeSci Biotech Products ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBP

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings27.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

5.567M
Healthcare

Xeris Biopharma Holdings Inc

3.554M
Healthcare

Kiniksa Pharmaceuticals International PLC Class A

2.573M
Healthcare

Iovance Biotherapeutics Inc

2.403M
Healthcare

ADMA Biologics Inc

2.283M
Healthcare

Verastem Inc

2.203M
Healthcare

Omeros Corp

2.153M
Healthcare

Regeneron Pharmaceuticals Inc

2.143M
Healthcare

BeOne Medicines Ltd ADR

2.103M
Healthcare

Insmed Inc

2.053M
Healthcare

Sponsor Center